BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10842199)

  • 1. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.
    Mantovani G; Macciò A; Melis G; Mura L; Massa E; Mudu MC
    Int J Cancer; 2000 Jun; 86(6):842-7. PubMed ID: 10842199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress.
    Mantovani G; Macciò A; Madeddu C; Mura L; Gramignano G; Lusso MR; Massa E; Mocci M; Serpe R
    J Mol Med (Berl); 2003 Oct; 81(10):664-73. PubMed ID: 12928788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
    Mantovani G; Macciò A; Esu S; Lai P; Santona MC; Massa E; Dessì D; Melis GB; Del Giacco GS
    Eur J Cancer; 1997 Apr; 33(4):602-7. PubMed ID: 9274442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships betxween Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions.
    Mantovani G; Macciò A; Massa E; Lai P; Manca G; Mudu C; Versace R; Pusceddu G
    Oncol Rep; 1999; 6(1):235-9. PubMed ID: 9864435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
    Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
    Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patients.
    Frydecka I; Mazur G
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):127-30. PubMed ID: 8915517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells - chemically injured keratocyte reaction.
    Yi K; Chung TY; Hyon JY; Koh JW; Wee WR; Shin YJ
    Mol Vis; 2011; 17():2665-71. PubMed ID: 22065919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.
    Mantovani G; Macciò A; Astara G; Contini L; Esu S; Littera S; Arangino V; Lai P; Proto E; Pusceddu G
    Cell Biophys; 1993; 22(1-3):79-99. PubMed ID: 7889544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of peripheral blood lymphocyte subset distribution and IL-2 receptor (IL-2 R) p55-p75 subunit expression in patients with cancer of different sites.
    Mantovani G; Macciò A; Lai P; Turnu E; Del Giacco GS
    Cell Biophys; 1994; 24-25():301-5. PubMed ID: 7736535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1 alpha, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies.
    Mantovani G; Macciò A; Lai P; Ghiani M; Turnu E; Del Giacco GS
    Cell Biophys; 1995 Aug; 27(1):1-14. PubMed ID: 7493395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.
    Mantovani G; Macciò A; Versace R; Pisano M; Lai P; Esu S; Ghiani M; Dessì D; Turnu E; Santona MC
    J Mol Med (Berl); 1995 Aug; 73(8):409-16. PubMed ID: 8528743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.
    Treiber-Held S; Stewart DM; Barraclough HA; Kurman CC; Nelson DL
    Clin Immunol Immunopathol; 1996 Jul; 80(1):67-75. PubMed ID: 8674241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
    Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
    Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of stress on interleukin-2 receptor expression by bovine mononuclear leukocytes.
    Lan HC; Reddy PG; Chambers MA; Walker G; Srivastava KK; Ferguson JA
    Vet Immunol Immunopathol; 1995 Dec; 49(3):241-9. PubMed ID: 8746698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen.
    Romano MF; Bisogni R; Lamberti A; Turco MC; Petrella A; Tassone P; Van Lier R; Formisano S; Venuta S
    Cell Immunol; 1994 Jul; 156(2):371-7. PubMed ID: 8025954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
    Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3- and CD28-activating pathways in HCV infection.
    Corado JA; Toro FI; Baroja ML; Bianco NE; Machado IV
    Viral Immunol; 1994; 7(1):37-40. PubMed ID: 7986335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.
    Contasta I; Pellegrini P; Berghella AM; Del Beato T; Canossi A; Di Rocco M; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):373-83. PubMed ID: 10851498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation, interleukin-2 production and receptor expression in peripheral blood mononuclear cells from colorectal cancer patients.
    Chang KJ; Wang SM; Lee CS; Hsieh KH; Chen KM
    J Formos Med Assoc; 1990 Mar; 89(3):205-13. PubMed ID: 1974593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.